Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Oxidative Stress in Parkinson's Disease

Identifieur interne : 000D21 ( Main/Exploration ); précédent : 000D20; suivant : 000D22

Oxidative Stress in Parkinson's Disease

Auteurs : Chun Zhou ; Yong Huang ; Serge Przedborski [États-Unis]

Source :

RBID : ISTEX:81C7E6C306D3A01532E0D629789054A211CA11B3

English descriptors

Abstract

Parkinson's disease (PD) is a common adult‐onset neurodegenerative disorder. Typically PD is a sporadic neurological disorder, and over time affected patients see their disability growing and their quality of life declining. Oxidative stress has been hypothesized to be linked to both the initiation and the progression of PD. Preclinical findings from both in vitro and in vivo experimental models of PD suggest that the neurodegenerative process starts with otherwise healthy neurons being hit by some etiological factors, which sets into motion a cascade of deleterious events. In these models initial molecular alterations in degenerating dopaminergic neurons include increased formation of reactive oxygen species, presumably originating from both inside and outside the mitochondria. In the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) mouse model of PD, time‐course experiments suggest that oxidative stress is an early event that may directly kill some of the dopaminergic neurons. In this model it seems that oxidative stress may play a greater role in the demise of dopaminergic neurons indirectly by activating intracellular, cell death‐related, molecular pathways. As the neurodegenerative process evolves in the MPTP mouse model, indices of neuroinflammation develop, such as microglial activation. The latter increases the level of oxidative stress to which the neighboring compromised neurons are subjected to, thereby promoting their demise. However, these experimental studies have also shown that oxidative stress is not the sole deleterious factor implicated in the death of dopaminergic neurons. Should a similar multifactorial cascade underlie dopaminergic neuron degeneration in PD, then the optimal therapy for this disease may have to rely on a cocktail of agents, each targeting a different critical component of this hypothesized pathogenic cascade. If correct, this may be a reason why neuroprotective trials using a single agent, such as an antioxidant, have thus far generated disappointing results.

Url:
DOI: 10.1196/annals.1427.023


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Oxidative Stress in Parkinson's Disease</title>
<author>
<name sortKey="Zhou, Chun" sort="Zhou, Chun" uniqKey="Zhou C" first="Chun" last="Zhou">Chun Zhou</name>
</author>
<author>
<name sortKey="Huang, Yong" sort="Huang, Yong" uniqKey="Huang Y" first="Yong" last="Huang">Yong Huang</name>
</author>
<author>
<name sortKey="Przedborski, Serge" sort="Przedborski, Serge" uniqKey="Przedborski S" first="Serge" last="Przedborski">Serge Przedborski</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:81C7E6C306D3A01532E0D629789054A211CA11B3</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1196/annals.1427.023</idno>
<idno type="url">https://api.istex.fr/document/81C7E6C306D3A01532E0D629789054A211CA11B3/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000A16</idno>
<idno type="wicri:Area/Main/Curation">000886</idno>
<idno type="wicri:Area/Main/Exploration">000D21</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Oxidative Stress in Parkinson's Disease</title>
<author>
<name sortKey="Zhou, Chun" sort="Zhou, Chun" uniqKey="Zhou C" first="Chun" last="Zhou">Chun Zhou</name>
<affiliation>
<wicri:noCountry code="no comma">Department of Neurology</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Huang, Yong" sort="Huang, Yong" uniqKey="Huang Y" first="Yong" last="Huang">Yong Huang</name>
<affiliation>
<wicri:noCountry code="no comma">Department of Neurology</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Przedborski, Serge" sort="Przedborski, Serge" uniqKey="Przedborski S" first="Serge" last="Przedborski">Serge Przedborski</name>
<affiliation>
<wicri:noCountry code="no comma">Department of Neurology</wicri:noCountry>
</affiliation>
<affiliation wicri:level="4">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Departments of Pathology and Cell Biology, Columbia University, New York, New York</wicri:regionArea>
<placeName>
<region type="state">État de New York</region>
<settlement type="city">New York</settlement>
</placeName>
<orgName type="university">Université Columbia</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Annals of the New York Academy of SciencesMitochondria and Oxidative Stress in Neurodegenerative Disorders</title>
<idno type="ISSN">0077-8923</idno>
<idno type="eISSN">1749-6632</idno>
<imprint>
<publisher>Blackwell Publishing Inc</publisher>
<pubPlace>Malden, USA</pubPlace>
<date type="published" when="2008-12">2008-12</date>
<biblScope unit="volume">1147</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="93">93</biblScope>
<biblScope unit="page" to="104">104</biblScope>
</imprint>
<idno type="ISSN">0077-8923</idno>
</series>
<idno type="istex">81C7E6C306D3A01532E0D629789054A211CA11B3</idno>
<idno type="DOI">10.1196/annals.1427.023</idno>
<idno type="ArticleID">NYAS1147023</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0077-8923</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Parkinson's disease</term>
<term>oxidative stress</term>
<term>reactive oxygen species</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Parkinson's disease (PD) is a common adult‐onset neurodegenerative disorder. Typically PD is a sporadic neurological disorder, and over time affected patients see their disability growing and their quality of life declining. Oxidative stress has been hypothesized to be linked to both the initiation and the progression of PD. Preclinical findings from both in vitro and in vivo experimental models of PD suggest that the neurodegenerative process starts with otherwise healthy neurons being hit by some etiological factors, which sets into motion a cascade of deleterious events. In these models initial molecular alterations in degenerating dopaminergic neurons include increased formation of reactive oxygen species, presumably originating from both inside and outside the mitochondria. In the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) mouse model of PD, time‐course experiments suggest that oxidative stress is an early event that may directly kill some of the dopaminergic neurons. In this model it seems that oxidative stress may play a greater role in the demise of dopaminergic neurons indirectly by activating intracellular, cell death‐related, molecular pathways. As the neurodegenerative process evolves in the MPTP mouse model, indices of neuroinflammation develop, such as microglial activation. The latter increases the level of oxidative stress to which the neighboring compromised neurons are subjected to, thereby promoting their demise. However, these experimental studies have also shown that oxidative stress is not the sole deleterious factor implicated in the death of dopaminergic neurons. Should a similar multifactorial cascade underlie dopaminergic neuron degeneration in PD, then the optimal therapy for this disease may have to rely on a cocktail of agents, each targeting a different critical component of this hypothesized pathogenic cascade. If correct, this may be a reason why neuroprotective trials using a single agent, such as an antioxidant, have thus far generated disappointing results.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>État de New York</li>
</region>
<settlement>
<li>New York</li>
</settlement>
<orgName>
<li>Université Columbia</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Huang, Yong" sort="Huang, Yong" uniqKey="Huang Y" first="Yong" last="Huang">Yong Huang</name>
<name sortKey="Zhou, Chun" sort="Zhou, Chun" uniqKey="Zhou C" first="Chun" last="Zhou">Chun Zhou</name>
</noCountry>
<country name="États-Unis">
<region name="État de New York">
<name sortKey="Przedborski, Serge" sort="Przedborski, Serge" uniqKey="Przedborski S" first="Serge" last="Przedborski">Serge Przedborski</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D21 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D21 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:81C7E6C306D3A01532E0D629789054A211CA11B3
   |texte=   Oxidative Stress in Parkinson's Disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024